Your browser doesn't support javascript.
loading
Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review.
Ebada, Mahmoud A; Alkanj, Souad; Ebada, Mohamed; Abdelkarim, Ahmed H; Diab, Ahmed; Aziz, Mohamed A E; Soliman, Ahmed M; Fayed, Notila; Bahbah, Eshak I; Negida, Ahmed.
Affiliation
  • Ebada MA; Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Alkanj S; Medical Research Group of Egypt.
  • Ebada M; Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Abdelkarim AH; Medical Research Group of Egypt.
  • Diab A; Al-Ahrar Teaching Hospital, Kafr El-Ahrar, Egypt.
  • Aziz MAE; Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Soliman AM; Medical Research Group of Egypt.
  • Fayed N; Medical Research Group of Egypt.
  • Bahbah EI; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Negida A; Medical Research Group of Egypt.
CNS Neurol Disord Drug Targets ; 18(4): 317-325, 2019.
Article in En | MEDLINE | ID: mdl-30868968
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Levodopa / Dyskinesia, Drug-Induced / Levetiracetam / Anticonvulsants / Antiparkinson Agents Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: CNS Neurol Disord Drug Targets Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Levodopa / Dyskinesia, Drug-Induced / Levetiracetam / Anticonvulsants / Antiparkinson Agents Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: CNS Neurol Disord Drug Targets Year: 2019 Document type: Article